Mistletoe Complementary Treatment in Patients with Primary Non-metastatic Breast Cancer
  

<< back

By: Paul R. Bock et al.
Courtesy Weleda USA

Mistletoe Complementary Treatment in Patients with Primary Non-metastatic Breast Cancer. By Paul R. Bock et al.

Category: Cancer and Iscador

Published by `Arzneim.-Forsch./Drug Research' on 10/1/2004

Summary: The results of the present study confirmed the safety of the complementary therapy for patients with primary, non-metastatic mammary carcinoma with Iscador ® and showed considerably fewer ADRs attributed to concurrent conventional therapy, as well as reduced disease and treatment-associated symptoms, and suggested a prolonged overall survival in the Iscador ® group as compared with controls.


Read Full Article (.PDF format)




<< back

Dynamic Content Management by ContentTrakker